Primary Care Perspective on Chronic Obstructive Pulmonary Disease Management

References

• . World Health Organization. Chronic obstructive pulmonary disease. Fact sheet No. 315. 2010. http://www.who.int/mediacentre/factsheets/fs315/en/index.html. Last updated 2011. Accessed March 3, 2011
   Google Scholar
• . Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971–2000. Respir Care. 2002;47(10):1184–1199
   PubMedGoogle Scholar
• . World Health Organization. World Health Statistics 2008. http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf. Last updated 2008. Accessed September 8, 2009
   Google Scholar
• . Centers for Disease Control and Prevention (CDC). Deaths from chronic obstructive pulmonary disease–United States, 2000–2005. MMWR Morb Mortal Wkly Rep. 2008;57(45):1229–1232
   PubMedGoogle Scholar
• . Cooper CB, Dransfield M. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease. Am J Med. 2008;121( 7 suppl): S33–S45
   PubMed Web of Science ®Google Scholar
• . Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2009. http://www.goldcopd.org. Last updated 2009. Accessed January 7, 2010
   Google Scholar
• . Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185
   PubMed Web of Science ®Google Scholar
• . Cruse MA. The impact of change in exercise tolerance on activities of daily living and quality of life in COPD: a patient's perspective. COPD. 2007;4(3):279–281
   PubMedGoogle Scholar
• . Rennard S, Decramer M, Calverley PM, . Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002;20(4):799–805
   PubMed Web of Science ®Google Scholar
• . Chapman KR, Bourbeau J, Rance L. The burden of COPD in Canada: results from the Confronting COPD survey. Respir Med. 2003;97( suppl C):S23–S31
   PubMed Web of Science ®Google Scholar
• . Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med. 2004;25(2):331–341
   PubMed Web of Science ®Google Scholar
• . Chang J, Mosenifar Z. Differentiating COPD from asthma in clinical practice. J Intensive Care Med. 2007;22(5):300–309
   PubMedGoogle Scholar
• . American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818–900
   PubMed Web of Science ®Google Scholar
• . Albers M, Schermer T, Molema J, . Do family physicians' records fit guideline diagnosed COPD? Fam Pract. 2009;26(2):81–87
   PubMed Web of Science ®Google Scholar
• . Barnett M. Chronic obstructive pulmonary disease: a phenomenological study of patients' experiences. J Clin Nurs. 2005;14(7):805–812
   PubMed Web of Science ®Google Scholar
• . ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD. 2007;4(3):293–297
   PubMedGoogle Scholar
• . Celli BR, MacNee W, Agusti A, . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946
   PubMed Web of Science ®Google Scholar
• . Kuebler KK, Buchsel PC, Balkstra CR. Differentiating chronic obstructive pulmonary disease from asthma. J Am Acad Nurse Pract. 2008;20(9):445–454
   PubMedGoogle Scholar
• . Price DB, Tinkelman DG, Halbert RJ, . Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285–295
   PubMed Web of Science ®Google Scholar
• . Bailey WC, Sciurba FC, Hanania NA, . Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009;18(3):198–207
   PubMedGoogle Scholar
• . Müllerová H, Wedzicha J, Soriano JB, Vestbo J. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med. 2004;98(1):78–83
   PubMed Web of Science ®Google Scholar
• . Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654
   PubMed Web of Science ®Google Scholar
• . Tinkelman DG, Price DB, Nordyke RJ, . Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006;73(3):296–305
   PubMed Web of Science ®Google Scholar
• . Make BJ, Martinez FJ. Assessment of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(9):884–890
   PubMedGoogle Scholar
• . Celli BR, Cote CG, Marin JM, . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012
   PubMed Web of Science ®Google Scholar
• . Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586
   PubMed Web of Science ®Google Scholar
• . National Institute for Clinical Excellence. Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). This guideline partially updates and replaces NICE clinical guideline 12. 2010. http://guidance.nice.org.uk/CG101. Last updated October 21. Accessed November 25, 2010
   Google Scholar
• . Jenkins C. COPD management. Part I. Strategies for managing the burden of established COPD. Int J Tuberc Lung Dis. 2008;12(6):586–594
   PubMed Web of Science ®Google Scholar
• . Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–105
   PubMed Web of Science ®Google Scholar
• . Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931
   PubMed Web of Science ®Google Scholar
• . Hurst J, Wedzicha J. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med. 2009;7(1):40
   PubMedGoogle Scholar
• . Belfer MH. The impact of exercise on activities of daily living and quality of life: a primary care physician's perspective. COPD. 2007;4(3):289–291
   PubMedGoogle Scholar
• . Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63(9):831–838
   PubMed Web of Science ®Google Scholar
• . Li AP. An integrated, multidisciplinary approach for drug safety assessment. Drug Discov Today. 2004;9(16):687–693
   PubMed Web of Science ®Google Scholar
• . Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345(13):941–947
   PubMed Web of Science ®Google Scholar
• . Ferguson GT, Calverley PM, Anderson JA, . Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest. 2009;136(6):1456–1465
   PubMed Web of Science ®Google Scholar
• . Soumerai SB, Pierre-Jacques M, Zhang F, . Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166(17):1829–1835
   PubMed Web of Science ®Google Scholar
• . Restrepo RD. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review. Respir Care. 2009;54(8):1058–1081
   PubMed Web of Science ®Google Scholar
• . Calverley P, Pauwels R, Vestbo J, . Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003;361(9356):449–456
   PubMed Web of Science ®Google Scholar
• . Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S. Additive effects of salmeterol and fluticasone or theophylline in COPD. Chest. 2000;118(6):1576–1581
   PubMed Web of Science ®Google Scholar
• . Mahler DA, Wire P, Horstman D, . Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(8):1084–1091
   PubMed Web of Science ®Google Scholar
• . Szafranski W, Cukier A, Ramirez A, . Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(1):74–81
   PubMed Web of Science ®Google Scholar
• . Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Respir Med. 2008;102(8):1099–1108
   PubMed Web of Science ®Google Scholar
• . Nannini LJ, Cates CJ, Lasserson TJ, Poole P. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007(4):CD006829
   Google Scholar
• . Rennard SI, Tashkin DP, McElhattan J, . Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. Drugs. 2009;69(5):549–565
   PubMed Web of Science ®Google Scholar
• . Calverley PM, Anderson JA, Celli B, . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789
   PubMed Web of Science ®Google Scholar
• . Jenkins C, Jones P, Calverley P, . Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009;10:59
   PubMed Web of Science ®Google Scholar
• . Celli BR, Thomas NE, Anderson JA, . Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332–338
   PubMed Web of Science ®Google Scholar
• . Crim C, Calverley PMA, Anderson JA, . Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J. 2009;34(3):641–647
   PubMed Web of Science ®Google Scholar
• . Barr RG, Bourbeau J, Camargo CA, Ram FS. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. Thorax. 2006;61(10):854–862
   PubMed Web of Science ®Google Scholar
• . Rodrigo GJ, Nannini LJ. Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis. Pulm Pharmacol Ther. 2007;20(5):495–502
   PubMed Web of Science ®Google Scholar
• . Kesten S, Jara M, Wentworth C, Lanes S. Pooled clinical trial analysis of tiotropium safety. Chest. 2006;130(6):1695–1703
   PubMed Web of Science ®Google Scholar
• . Tashkin DP, Celli B, Senn S, ; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554
   PubMed Web of Science ®Google Scholar
• . Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171–1178
   PubMed Web of Science ®Google Scholar
• . Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP; UPLIFT Study Investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(10):948–955
   PubMed Web of Science ®Google Scholar
• . Aaron SD, Vandemheen KL, Fergusson D, ; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for treatment of chronic obstructive pulmonary disease. Ann Intern Med. 2007;146(8):545–555
   PubMed Web of Science ®Google Scholar
• . Lee TA, Wilke C, Joo M, . Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med. 2009;169(15):1403–1410
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. Vaccines and preventable diseases: pneumococcal disease in-short. 2010. http://www.cdc.gov/vaccines/vpd-vac/pneumo/in-short-both.htm#who. Last updated April 23, 2010. Accessed June 11, 2010
   Google Scholar
• . Anthonisen NR, Connett JE, Kiley JP, . Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study. JAMA. 1994;272(19):1497–1505
   PubMed Web of Science ®Google Scholar
• . Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality. Ann Intern Med. 2005;142(4):233–239
   PubMed Web of Science ®Google Scholar
• . Meulepas MA, Jacobs JE, Smeenk FW, . Effect of an integrated primary care model on the management of middle-aged and old patients with obstructive lung diseases. Scand J Prim Health Care. 2007;25(3):186–192
   PubMed Web of Science ®Google Scholar
• . Ries AL, Bauldoff GS, Carlin BW, . Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131( 5 suppl):4S–2S
   PubMed Web of Science ®Google Scholar
• . Zieliński J, Tobiasz M, Hawryłkiewicz I, Śliwiński P, Pałasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients. Chest. 1998;113(1):65–70
   PubMed Web of Science ®Google Scholar
• . Make B, Krachman S, Panos RJ, Doherty DE, Stoller JK. Oxygen therapy in advanced COPD: in whom does it work? Semin Respir Crit Care Med. 2010;31(3):334–342
   PubMed Web of Science ®Google Scholar
• . Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B; Long-term Oxygen Treatment Trial Research Group. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest. 2010;138(1):179–187
   PubMed Web of Science ®Google Scholar
• . Naunheim KS, Wood DE, Mohsenifar Z, . Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82(2):431–443
   PubMed Web of Science ®Google Scholar
• . Patel N, DeCamp M, Criner GJ. Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):447–453
   PubMedGoogle Scholar
• . Welte T, Miravitlles M, Hernandez P, . Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741–750
   PubMed Web of Science ®Google Scholar